Temozolomide

CD4 molecule ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35624211 Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression. 2022 Jun 1
2 33987112 Should CD4 Levels be Monitored in a Patient on Temozolomide? 2021 6
3 30829928 Exceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma. 2019 Dec 1
4 28806010 Blastomycosis and Histoplasmosis in a Patient with Glioblastoma Receiving Temozolomide. 2016 Oct 1
5 25655312 T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenoviruses. 2015 May 1
6 26070554 Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas. 2015 Sep 1
7 24197135 Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggering. 2014 Jan 1 1
8 23725550 Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients. 2013 May 31 1
9 24019780 Aspergillosis in a patient receiving temozolomide for the treatment of glioblastoma. 2013 2
10 21737504 Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. 2011 Aug 15 1
11 18715650 Disseminated salmonellosis in a patient treated with temozolomide. 2008 Nov 1
12 16925485 Temozolomide: a milestone in neuro-oncology and beyond? 2006 Aug 1
13 14726505 Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. 2004 Feb 15 3